Invention Grant
US08945577B2 Fusion proteins and combination vaccines comprising Haemophilus influenzae Protein E and Pilin A
有权
融合蛋白和包含流感嗜血杆菌蛋白E和Pilin A的组合疫苗
- Patent Title: Fusion proteins and combination vaccines comprising Haemophilus influenzae Protein E and Pilin A
- Patent Title (中): 融合蛋白和包含流感嗜血杆菌蛋白E和Pilin A的组合疫苗
-
Application No.: US14110857Application Date: 2012-04-12
-
Publication No.: US08945577B2Publication Date: 2015-02-03
- Inventor: Normand Blais , Steve Labbe , Jan Poolman
- Applicant: Normand Blais , Steve Labbe , Jan Poolman
- Applicant Address: BE Rixensart
- Assignee: GlaxoSmithKline Biologicals S.A.
- Current Assignee: GlaxoSmithKline Biologicals S.A.
- Current Assignee Address: BE Rixensart
- Agent Alice P. Bradney
- International Application: PCT/CA2012/050236 WO 20120412
- International Announcement: WO2012/139225 WO 20121018
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/385 ; A61K39/102 ; C07K1/00 ; C07K14/00 ; C07K17/00 ; C12P21/08 ; C07K14/285
Abstract:
The present invention relates to compositions comprising Haemophilus influenzae Protein E and Pilin A. More particularly, the present application relates to fusion proteins and immunogenic compositions comprising Protein E and PilA, vaccines comprising such immunogenic compositions and therapeutic uses of the same.
Public/Granted literature
- US20140056934A1 FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A Public/Granted day:2014-02-27
Information query
